2RM-53694-51771
2 vaccinations
1 coded response
10 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 100 / NY
- Registered
- 2021-02-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-16
Dose 1 — Pfizer-BioNTech
-
2021-02-21
Registered in v-safe
- 2021-02-21
- 2021-02-25
- 2021-03-02
-
2021-03-05
Dose 2 — Pfizer-BioNTech
- 2021-03-09
- 2021-03-14
-
2021-03-19
Survey response — day 14, dose 2MedDRA: Mastitis — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: MastitisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-19
Report sent to call center — day 14, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-03-26
- 2021-04-02
- 2021-04-16
- 2021-09-03
- 2021-12-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-16 | Pfizer-BioNTech | |
| 2 | 2021-03-05 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-19 | Unsuccessful |
Free text
Release 6 — day 14, dose 2
Symptoms: Mastitis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Mastitis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release